CHOLESTEROL ABSORPTIONS INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

Details for Australian Patent Application No. 2003291719 (hide)

Owner SCHERING CORPORATION

Inventors VELTRI, Enrico, P.; ERBEY, John, R., II; FINE, Jay, S.

Pub. Number AU-A-2003291719

PCT Number PCT/US2003/0350

PCT Pub. Number WO2004/043457

Priority 60/424,165 06.11.02 US; 60/493,318 07.08.03 US

Filing date 4 November 2003

Wipo publication date 3 June 2004

International Classifications

A61K 031/397 - having four-membered rings, e.g. azetidine

A61P 037/00 Drugs for immunological or allergic disorders

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 60/424,165 06.11.02 US; 60/493,318 07.08.03 US

8 July 2004 Application Open to Public Inspection

  Published as AU-A-2003291719

21 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003291720-COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MOOD DISORDERS

2003291718-RELEASE OF THE SELFQUENCHING OF FLUORESCENCE NEAR SILVER METALLIC SURFACES